Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Drugs|September 15, 2010
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555Sergio Leonardi, Pierluigi Tricoci, Richard C Becker
Current Opinion in Cardiology|June 11, 2009
A new generation of antiplatelet agentsMatthew B Sellers, Pierluigi Tricoci, Robert A Harrington
The American Journal of Cardiology|December 16, 2006
Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initiative)Pierluigi Tricoci, Eric D Peterson, Matthew T Roe, et al.
Expert Review of Cardiovascular Therapy|May 11, 2007
Present and evolving role of eptifibatide in the treatment of acute coronary syndromesPierluigi Tricoci, L Kristin Newby, David E Kandzari, et al.
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Clinical use of novel antithrombotic agents in the management of acute coronary syndromesGiovanni Melandri, Pierluigi Tricoci, Chiara Melloni, et al.
JAMA|February 27, 2009
Scientific evidence underlying the ACC/AHA clinical practice guidelinesPierluigi Tricoci, Joseph M Allen, Judith M Kramer, et al.
Journal of Cardiovascular Electrophysiology|April 9, 2005
Quantification of fatty tissue mass by magnetic resonance imaging in arrhythmogenic right ventricular dysplasiaRossella Fattori, Pierluigi Tricoci, Vincenzo Russo, et al.
International Journal of Cardiology|April 18, 2013
Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: a meta-analysis of randomized trialsMarco Valgimigli, Seung-Jung Park, Hyo-Soo Kim, et al.
British Journal of Clinical Pharmacology|November 20, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patientsBo Zheng, Danielle Duffy, Pierluigi Tricoci, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphismsSamuele Nanni, Giovanni Melandri, Roeland Hanemaaijer, et al.
Pageof 10